Mutual of America Capital Management LLC has increased their position in Bio-Rad Laboratories. So have Natixis Advisors LLC, Mawer Investment Management Ltd. , and Harbor Capital Advisors Inc.. On the other hand, CIBC Asset Management Inc and Thompson Siegel & Walmsley LLC have both sold shares. The perception of Bio-Rad Laboratories as an attractive investment is mixed. Despite recent losses in the BIO stock value, with shareholders enduring a 54% loss over three years, certain firms like BIO Q3 and Entropy Technologies LP still see potential. Bio-Rad has beat Q3 earnings and revenue estimates and this reflected in ascending stock values in the aftermarket. Kornitzer Capital Management Inc. KS maintains a significant stake in Bio-Rad. However, the company had to cut its annual revenue forecast due to weak demand for diagnostic products and shared slipped after the company reiterated its 2024 growth outlook . Despite some setbacks, Bio-Rad reported solid growth and increasing net income in Q3 2024. Overall, opinions on Bio-Rad Laboratories are mixed, with some entities expressing confidence in its future performance, while others express caution.
Bio-Rad Laboratories Stocks News Analytics from Thu, 14 Jul 2016 07:00:00 GMT to Sat, 23 Nov 2024 08:37:54 GMT -
Rating -3
- Innovation 0
- Information 8
- Rumor -4
